AU9067791A - Method of enhancing long-term storage stability of hemoglobin products - Google Patents
Method of enhancing long-term storage stability of hemoglobin productsInfo
- Publication number
- AU9067791A AU9067791A AU90677/91A AU9067791A AU9067791A AU 9067791 A AU9067791 A AU 9067791A AU 90677/91 A AU90677/91 A AU 90677/91A AU 9067791 A AU9067791 A AU 9067791A AU 9067791 A AU9067791 A AU 9067791A
- Authority
- AU
- Australia
- Prior art keywords
- storage stability
- term storage
- enhancing long
- hemoglobin products
- hemoglobin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000001554 Hemoglobins Human genes 0.000 title 1
- 108010054147 Hemoglobins Proteins 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 230000007774 longterm Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61612890A | 1990-11-20 | 1990-11-20 | |
| US616128 | 1990-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU9067791A true AU9067791A (en) | 1992-06-11 |
Family
ID=24468160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU90677/91A Abandoned AU9067791A (en) | 1990-11-20 | 1991-11-19 | Method of enhancing long-term storage stability of hemoglobin products |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU9067791A (en) |
| WO (1) | WO1992008478A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5312808A (en) * | 1989-11-22 | 1994-05-17 | Enzon, Inc. | Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
| US5650388A (en) * | 1989-11-22 | 1997-07-22 | Enzon, Inc. | Fractionated polyalkylene oxide-conjugated hemoglobin solutions |
| ATE222926T1 (en) * | 1995-03-23 | 2002-09-15 | Biopure Corp | STABLE POLYMERIZED HEMOGLOBIN BLOOD SUBSTITUTE |
| US5929031A (en) * | 1995-05-02 | 1999-07-27 | Baxter Biotech Technology Sarl | Storage stable hemoglobin solutions |
| JP3466516B2 (en) | 1999-09-07 | 2003-11-10 | 科学技術振興事業団 | Stable oxygen storage solution |
| US7494974B2 (en) | 2006-10-24 | 2009-02-24 | Ikor, Inc. | Carboxymethylated cross-linked tetrameric hemoglobin |
| US7504377B2 (en) | 2006-10-23 | 2009-03-17 | Ikor, Inc. | Nitric oxide-blocked cross-linked tetrameric hemoglobin |
| WO2025047854A1 (en) * | 2023-08-31 | 2025-03-06 | 公立大学法人奈良県立医科大学 | Method and apparatus for exchanging dissolved gas in hemoglobin-containing solution |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3144705C2 (en) * | 1981-11-11 | 1983-12-08 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Process for the production of a storage-stable, cross-linked hemoglobin preparation with high oxygen transport capacity, as well as the hemoglobin preparation produced by this process |
| US4831012A (en) * | 1984-03-23 | 1989-05-16 | Baxter International Inc. | Purified hemoglobin solutions and method for making same |
| DE3675588D1 (en) * | 1985-06-19 | 1990-12-20 | Ajinomoto Kk | HAEMOGLOBIN TIED TO A POLY (ALKENYLENE OXIDE). |
| US4826811A (en) * | 1986-06-20 | 1989-05-02 | Northfield Laboratories, Inc. | Acellular red blood cell substitute |
| DE3636590A1 (en) * | 1986-10-28 | 1988-05-26 | Braun Melsungen Ag | BLOOD REPLACEMENT |
| GB8710598D0 (en) * | 1987-05-05 | 1987-06-10 | Star Medical Diagnostics Ltd | Hemoglobin based blood substitute |
-
1991
- 1991-11-19 AU AU90677/91A patent/AU9067791A/en not_active Abandoned
- 1991-11-19 WO PCT/US1991/008622 patent/WO1992008478A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992008478A1 (en) | 1992-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9117765D0 (en) | Method of improving storage stability | |
| AU3881789A (en) | Smoking article | |
| AU4456689A (en) | Smoking article | |
| AU2766889A (en) | Laser tipped catheter | |
| AU639483B2 (en) | Smoking articles | |
| AU8554791A (en) | Smoking article | |
| AU4544489A (en) | Castors | |
| AU7735691A (en) | Food storage | |
| AU541562B2 (en) | Vascular prosthesis | |
| AU2274988A (en) | Foam-honeycomb article and method | |
| AU9111991A (en) | Preparation of foam-in-fabric articles | |
| AU6759690A (en) | Storage solution | |
| AU4575689A (en) | Smoking article | |
| AU3833293A (en) | Intermediate compounds of optically active triazole derivatives and methods of their production | |
| AU9067791A (en) | Method of enhancing long-term storage stability of hemoglobin products | |
| AU1028892A (en) | Phenoxyalkylcarboxylic acid derivatives and process of preparing the same | |
| AU1267988A (en) | Optically active oxo-isoindolinyl derivatives | |
| AU581120B2 (en) | An article of furniture | |
| AU8266691A (en) | Method of disinfection | |
| AU6661986A (en) | Smoking articles | |
| AU1297592A (en) | Method of preparing polyethercyclicopolyols | |
| AU1297492A (en) | Method of preparing polyethercyclicpolyols | |
| RU2003311C1 (en) | Method of blepharorrhaphy | |
| AU581390B2 (en) | Smoking articles | |
| AU7056391A (en) | Dermatologic preparation |